Neuropsychopharmacology
Neuropsychopharmacology, Published online: 09 September 2026; doi:10.1038/s41386-026-02546-4 Epigenetic markers of response to psychotherapy in obsessive-compulsive disorder
Neuropsychopharmacology, Published online: 10 September 2026; doi:10.1038/s41386-026-02550-8 Functional precision psychiatry: iPSC-derived neurons as predictive assays for antidepressant response
Neuropsychopharmacology, Published online: 09 September 2026; doi:10.1038/s41386-026-02555-3 Endocannabinoid control of the pain–stress axis
Neuropsychopharmacology, Published online: 08 September 2026; doi:10.1038/s41386-026-02542-8 Intermittent and extended cocaine access attenuate cocaine-vs-food choice in male and female rats
Neuropsychopharmacology, Published online: 08 September 2026; doi:10.1038/s41386-026-02553-5 In Memorium: Robert Bruce Lydiard, Ph.D., M.D.
Neuropsychopharmacology, Published online: 06 September 2026; doi:10.1038/s41386-026-02551-7 Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions
Menstrual cycle-dependent white matter microstructural dynamics in women with substance use disorder
Neuropsychopharmacology, Published online: 05 September 2026; doi:10.1038/s41386-026-02552-6 Menstrual cycle-dependent white matter microstructural dynamics in women with substance use disorder
Neuropsychopharmacology, Published online: 05 September 2026; doi:10.1038/s41386-026-02538-4 NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials
Neuropsychopharmacology, Published online: 04 September 2026; doi:10.1038/s41386-026-02543-7 Complex social dominance behavior using a novel platform test is associated with lateral habenula activation in male and female mice
Neuropsychopharmacology, Published online: 04 September 2026; doi:10.1038/s41386-026-02545-5 Correction: Shared genetic architecture and neurobiological pathways of problematic alcohol use and anxiety disorders
Neuropsychopharmacology, Published online: 01 September 2026; doi:10.1038/s41386-026-02541-9 Translating macaque frontopolar cortex discoveries into psychiatric treatments
Neuropsychopharmacology, Published online: 01 September 2026; doi:10.1038/s41386-026-02534-8 NMDA receptor ablation in medial prefrontal cortex disrupts value updating and reward history integration
Neuropsychopharmacology, Published online: 29 August 2026; doi:10.1038/s41386-026-02536-6 The role of BDNF promoter VI in mediating protective effects of prophylactic ( R,S )-ketamine
Neuropsychopharmacology, Published online: 27 August 2026; doi:10.1038/s41386-026-02535-7 Lithium as a therapeutic strategy for SNAP25 encephalopathies via modulation of homeostatic plasticity
Neuropsychopharmacology, Published online: 26 August 2026; doi:10.1038/s41386-026-02523-x Associations among mediodorsal thalamic-ventrolateral prefrontal cortical white matter fiber dispersion and OCD-related incompleteness
Neuropsychopharmacology, Published online: 26 August 2026; doi:10.1038/s41386-026-02508-w Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain
Neuropsychopharmacology, Published online: 27 August 2026; doi:10.1038/s41386-026-02539-3 A transient mitochondrial switch underlies long lasting effects of adolescent cannabis
Neuropsychopharmacology, Published online: 26 August 2026; doi:10.1038/s41386-026-02537-5 How indirect is too indirect? Structural pathways to the sgACC and the antidepressant response to TMS
Neuropsychopharmacology, Published online: 26 August 2026; doi:10.1038/s41386-026-02516-w Effects of prefrontal transcranial direct current stimulation on open-label placebo responses

research.ioSign up to keep scrolling
Create your feed subscriptions, save articles, keep scrolling.